{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:51:57Z","timestamp":1793836317726,"version":"4.6.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neurodegenerative diseases\u2014including Alzheimer\u2019s, Parkinson\u2019s, and amyotrophic lateral sclerosis (ALS)\u2014as well as autoimmune disorders with neurodegenerative features such as multiple sclerosis (MS), present an escalating global challenge. Current diagnostics often detect pathology too late, and most treatments focus on symptom relief rather than disease modification. There is an urgent need for tools that enable early detection and precision-targeted intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>Nanotechnology offers unique advantages in this space, enabling early molecular detection, targeted drug delivery, and theranostic systems. Engineered nanocarriers, biosensors, and responsive nanodevices are being tailored to disease-specific features such as oxidative stress in AD or neuroinflammation in MS. Yet, issues like biocompatibility, clinical scalability, and long-term safety remain barriers to translation. Artificial intelligence (AI) enhances nanomedicine by improving biomarker sensitivity, stratifying patients, and enabling predictive disease modeling. From AI-guided nanoparticle design to closed-loop delivery systems and digital twin models, these technologies work synergistically to support real-time, personalized care. Still, critical challenges\u2014including algorithmic bias, lack of explainability, heterogeneous datasets, and limited regulatory clarity\u2014impede clinical integration. Additionally, high system complexity and cost risk excluding low-resource settings unless inclusive, scalable alternatives are pursued.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The convergence of AI and nanotechnology is reshaping neurodegenerative disease care, moving from reactive to proactive, personalized neurology. Realizing this promise requires cross-sector collaboration, ethical foresight, and translational rigor to ensure these innovations are safe, equitable, and accessible to all patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-025-03719-x","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T16:43:31Z","timestamp":1760373811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Integrating artificial intelligence with nanodiagnostics for early detection and precision management of neurodegenerative diseases"],"prefix":"10.1186","volume":"23","author":[{"given":"Youssef M.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Wanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayat A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3622-1417","authenticated-orcid":false,"given":"Wael M.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"issue":"4","key":"3719_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson DM, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186(4):693\u2013714.","journal-title":"Cell"},{"issue":"18","key":"3719_CR2","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.3390\/cells12182318","volume":"12","author":"N Sanghai","year":"2023","unstructured":"Sanghai N, Tranmer GK. Biochemical and molecular pathways in neurodegenerative diseases: an integrated view. Cells. 2023;12(18):2318.","journal-title":"Cells"},{"issue":"3","key":"3719_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ma15030804","volume":"15","author":"T Bhattacharya","year":"2022","unstructured":"Bhattacharya T, Soares GA, Chopra H, Rahman MM, Hasan Z, Swain SS, et al. Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders. Materials. 2022;15(3):804.","journal-title":"Materials"},{"issue":"4s","key":"3719_CR4","doi-asserted-by":"publisher","first-page":"s1185","DOI":"10.5530\/ijper.58.4s.116","volume":"58","author":"R Palaniyappan","year":"2024","unstructured":"Palaniyappan R, Arthanari S, Subramanian M, Periyasamy P, Pethappachetty P, Ganesan R, Prakash M, Govindaraj A. Nanotechnology-driven approaches in overcoming drug delivery challenges for neurodegenerative diseases. Indian J Pharm Educ Res. 2024;58(4s):s1185\u2013200.","journal-title":"Indian J Pharm Educ Res"},{"key":"3719_CR5","doi-asserted-by":"publisher","unstructured":"Chaudhary S, Rawat S, Mathur S, Perveen A, Hafeez A, Bilgrami AL, Ashraf GM. Next-generation neurotherapeutics: nanotechnology, immunotherapy, and gene editing for neurodegenerative diseases. Neurodegenerative Disease Manage. 2025:1\u201320. https:\/\/doi.org\/10.1080\/17582024.2025.2520707","DOI":"10.1080\/17582024.2025.2520707"},{"key":"3719_CR6","unstructured":"Naziriz N, Demetzos C. Advanced technologies in health and neurodegenerative diseases. In: Vlamos P, Kotsireas IS, Tarnanas I, editors. Handbook of computational neurodegeneration. Cham: Springer International Publishing; 2023. p. 629\u201353."},{"issue":"1","key":"3719_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3762\/bjnano.15.47","volume":"15","author":"S He","year":"2024","unstructured":"He S, Abarrategi JS, Bediaga H, Arrasate S, Gonz\u00e1lez-D\u00edaz H. On the additive artificial intelligence-based discovery of nanoparticle neurodegenerative disease drug delivery systems. Beilstein J Nanotechnol. 2024;15(1):535\u201355.","journal-title":"Beilstein J Nanotechnol"},{"key":"3719_CR8","doi-asserted-by":"crossref","unstructured":"Halagali P, Nayak D, Rathnanand M, Tippavajhala VK, Sharma H, Biswas D. Synergizing sustainable green nanotechnology and AI\/ML for advanced nanocarriers: a paradigm shift in the treatment of neurodegenerative diseases. In: Koduru TS, Osmani RAM, Singh E, Dutta S, editors. The neurodegeneration revolution: Emerging Therapies and Sustainable Solutions. Academic; 2025. pp. 373\u201397.","DOI":"10.1016\/B978-0-443-28822-7.00017-9"},{"issue":"10","key":"3719_CR9","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1080\/1061186X.2024.2393417","volume":"32","author":"S Heydari","year":"2024","unstructured":"Heydari S, Masoumi N, Esmaeeli E, Ayyoubzadeh SM, Ghorbani-Bidkorpeh F, Ahmadi M. Artificial intelligence in nanotechnology for treatment of diseases. J Drug Target. 2024;32(10):1247\u201366.","journal-title":"J Drug Target"},{"key":"3719_CR10","doi-asserted-by":"crossref","unstructured":"Wal A, Singh MN, Vig H, Katul MK, Kumar BP, Kumar MU. Artificial intelligence and machine learning-based advances in the management of neurodegenerative diseases. In: Patil VM, Kumar D, Masand N, editors. Molecular targets and therapeutic interventions against neurodegenerative diseases. CRC; 2025. pp. 102\u201326.","DOI":"10.1201\/9781003506317-7"},{"issue":"1","key":"3719_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/odi.14054","volume":"29","author":"V Parra-Torres","year":"2023","unstructured":"Parra-Torres V, Melgar\u2010Rodr\u00edguez S, Mu\u00f1oz\u2010Manr\u00edquez C, Sanhueza B, Cafferata EA, Paula\u2010Lima AC, et al. Periodontal bacteria in the brain\u2014implication for Alzheimer\u2019s disease: a systematic review. Oral Dis. 2023;29(1):21\u20138.","journal-title":"Oral Dis"},{"issue":"1","key":"3719_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/1061186X.2021.1927055","volume":"30","author":"Q Ouyang","year":"2022","unstructured":"Ouyang Q, Meng Y, Zhou W, Tong J, Cheng Z, Zhu Q. New advances in brain-targeting nano-drug delivery systems for Alzheimer\u2019s disease. J Drug Target. 2022;30(1):61\u201381.","journal-title":"J Drug Target"},{"issue":"3","key":"3719_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20230048","volume":"4","author":"Q Feng","year":"2023","unstructured":"Feng Q, Zhang X, Zhang N, Gu H, Wang N, Chen J, et al. The dissolution, reassembly and further clearance of amyloid-\u03b2 fibrils by tailor-designed dissociable nanosystem for alzheimer\u2019s disease therapy. Exploration. 2023;4(3):20230048. https:\/\/doi.org\/10.1002\/EXP.20230048.","journal-title":"Exploration"},{"issue":"2","key":"3719_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41565-024-01801-3","volume":"20","author":"Y Liu","year":"2025","unstructured":"Liu Y, Liu R, Dong J, Xia X, Yang H, Wei S, Fan L, Fang M, Zou Y, Zheng M, Leong KW, Shi B. Targeted protein degradation via cellular trafficking of nanoparticles. Nat Nanotechnol. 2025;20(2):296\u2013302. https:\/\/doi.org\/10.1038\/s41565-024-01801-3.","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"3719_CR15","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/j.apsb.2022.02.001","volume":"12","author":"X He","year":"2022","unstructured":"He X, Wang X, Yang L, Yang Z, Yu W, Wang Y, et al. Intelligent lesion blood\u2013brain barrier targeting nano-missiles for Alzheimer\u2019s disease treatment by anti-neuroinflammation and neuroprotection. Acta Pharm Sin B. 2022;12(4):1987\u201399.","journal-title":"Acta Pharm Sin B"},{"issue":"29","key":"3719_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adma.202314354","volume":"36","author":"Y Liu","year":"2024","unstructured":"Liu Y, Xia X, Zheng M, Shi B. Bio\u2013nano toolbox for precision alzheimer\u2019s disease gene therapy. Adv Mater. 2024;36(29):1\u201326. https:\/\/doi.org\/10.1002\/adma.202314354.","journal-title":"Adv Mater"},{"issue":"10423","key":"3719_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of parkinson\u2019s disease. Lancet. 2024;403(10423):293\u2013304.","journal-title":"Lancet"},{"issue":"1","key":"3719_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94175-8","volume":"11","author":"V Monge-Fuentes","year":"2021","unstructured":"Monge-Fuentes V, Biolchi Mayer A, Lima MR, Geraldes LR, Zanotto LN, Moreira KG, et al. Dopamine-loaded nanoparticle systems circumvent the blood\u2013brain barrier restoring motor function in mouse model for parkinson\u2019s disease. Sci Rep. 2021;11(1):15185.","journal-title":"Sci Rep"},{"issue":"1","key":"3719_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(22)00184-3","volume":"22","author":"JS Graves","year":"2023","unstructured":"Graves JS, Krysko KM, Hua LH, Absinta M, Franklin RJ, Segal BM. Ageing and multiple sclerosis. Lancet Neurol. 2023;22(1):66\u201377.","journal-title":"Lancet Neurol"},{"issue":"1","key":"3719_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s10571-023-01434-5","volume":"44","author":"S Ghosh","year":"2024","unstructured":"Ghosh S, Bhatti GK, Sharma PK, Kandimalla R, Mastana SS, Bhatti JS. Potential of nano-engineered stem cells in the treatment of multiple sclerosis: a comprehensive review. Cell Mol Neurobiol. 2024;44(1):6.","journal-title":"Cell Mol Neurobiol"},{"issue":"7","key":"3719_CR21","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s10072-021-05234-x","volume":"42","author":"Z Asefy","year":"2021","unstructured":"Asefy Z, Hoseinnejhad S, Ceferov Z. Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment. Neurol Sci. 2021;42(7):2653\u201360.","journal-title":"Neurol Sci"},{"issue":"16","key":"3719_CR22","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1039\/D4NA00214H","volume":"6","author":"MA Darwish","year":"2024","unstructured":"Darwish MA, Abd-Elaziem W, Elsheikh A, Zayed AA. Advancements in nanomaterials for nanosensors: a comprehensive review. Nanoscale Adv. 2024;6(16):4015\u201346.","journal-title":"Nanoscale Adv"},{"key":"3719_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2021.109326","volume":"363","author":"JT Del Bonis-O\u2019Donnell","year":"2021","unstructured":"Del Bonis-O\u2019Donnell JT, Mun J, Delevich K, Landry MP. Synthetic nanosensors for imaging neuromodulators. J Neurosci Methods. 2021;363:109326.","journal-title":"J Neurosci Methods"},{"issue":"1","key":"3719_CR24","first-page":"72","volume":"13","author":"O V\u00e1zquez-Mena","year":"2023","unstructured":"V\u00e1zquez-Mena O, Flores-V\u00e1zquez V, Guti\u00e9rrez-S\u00e1nchez E, Flores-V\u00e1zquez S, G\u00f3mez-D\u00edaz S. A review of commercial and non-commercial wearables devices for monitoring motor impairments caused by neurodegenerative diseases. Biosensors. 2023;13(1):72.","journal-title":"Biosensors"},{"issue":"34","key":"3719_CR25","doi-asserted-by":"publisher","first-page":"22620","DOI":"10.1021\/acsnano.4c05200","volume":"18","author":"R Boudries","year":"2024","unstructured":"Boudries R, Williams H, Paquereau-Gaboreau S, Bashir S, Hojjat Jodaylami M, Chisanga M, Trudeau LE, Masson JF. Surface-enhanced Raman scattering nanosensing and imaging in neuroscience. ACS Nano. 2024;18(34):22620\u201347.","journal-title":"ACS Nano"},{"key":"3719_CR26","first-page":"13","volume":"111","author":"WM Lee","year":"2023","unstructured":"Lee WM, Lee SS. The use of blood biomarkers in neurodegenerative diseases. Clin Biochem. 2023;111:13\u201322.","journal-title":"Clin Biochem"},{"issue":"18","key":"3719_CR27","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.3390\/molecules28186624","volume":"28","author":"S Malik","year":"2023","unstructured":"Malik S, Muhammad K, Waheed Y. Emerging applications of nanotechnology in healthcare and medicine. Molecules. 2023;28(18):6624.","journal-title":"Molecules"},{"key":"3719_CR28","doi-asserted-by":"crossref","unstructured":"Feng T. Applications of artificial intelligence to diagnosis of neurodegenerative diseases. Stud Health Technol Inform 2023; 308:648-55. doi: 10.3233\/SHTI230896.","DOI":"10.3233\/SHTI230896"},{"issue":"2","key":"3719_CR29","first-page":"247","volume":"8","author":"K Cho","year":"2011","unstructured":"Cho K, Wang X, Nie S, Chen ZG, Shin DM. Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers. Expert Opin Drug Deliv. 2011;8(2):247\u201362.","journal-title":"Expert Opin Drug Deliv"},{"key":"3719_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.918715","volume":"10","author":"M Sivasubramanian","year":"2022","unstructured":"Sivasubramanian M, Lin LJ, Wang YC, Yang CS, Lo LW. Industrialization\u2019s eye view on theranostic nanomedicine. Front Chem. 2022;10:918715.","journal-title":"Front Chem"},{"issue":"4","key":"3719_CR31","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.talanta.2007.06.009","volume":"74","author":"MD Vestergaard","year":"2008","unstructured":"Vestergaard MD, Kerman K, Kim DK, Hiep HM, Tamiya E. Detection of Alzheimer\u2019s Tau protein using localised surface plasmon resonance-based immunochip. Talanta. 2008;74(4):1038\u201342.","journal-title":"Talanta"},{"issue":"12","key":"3719_CR32","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/s41565-024-01753-8","volume":"19","author":"L Rao","year":"2024","unstructured":"Rao L, Yuan Y, Shen X, Yu G, Chen X. Designing nanotheranostics with machine learning. Nat Nanotechnol. 2024;19(12):1769\u201378. https:\/\/doi.org\/10.1038\/s41565-024-01753-8.","journal-title":"Nat Nanotechnol"},{"issue":"9","key":"3719_CR33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/mi11090787","volume":"11","author":"Y Li","year":"2020","unstructured":"Li Y, Li D, Zhao P, Nandakumar K, Wang L, Song Y. Microfluidics-based systems in diagnosis of Alzheimer\u2019s disease and biomimetic modeling. Micromachines. 2020;11(9):787.","journal-title":"Micromachines"},{"key":"3719_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.bios.2015.03.032","volume":"70","author":"AI Barbosa","year":"2015","unstructured":"Barbosa AI, Gehlot P, Sidapra K, Edwards AD, Reis NM. Portable smartphone quantitation of prostate specific antigen (PSA) in a fluoropolymer microfluidic device. Biosens Bioelectron. 2015;70:5\u201314. https:\/\/doi.org\/10.1016\/j.bios.2015.03.032.","journal-title":"Biosens Bioelectron"},{"key":"3719_CR35","doi-asserted-by":"crossref","unstructured":"Zhang W. Blood-brain barrier (BBB)-crossing strategies for improved treatment of CNS disorders. In: Sch\u00e4fer-Korting M, Schubert US, editors. Drug delivery and targeting. Cham: Springer International Publishing; 2023. p. 213\u201330.","DOI":"10.1007\/164_2023_689"},{"issue":"2","key":"3719_CR36","doi-asserted-by":"publisher","first-page":"021301","DOI":"10.1063\/5.0079045","volume":"16","author":"H Cong","year":"2022","unstructured":"Cong H, Zhang N. Perspectives in translating microfluidic devices from laboratory prototyping into scale-up production. Biomicrofluidics. 2022;16(2):021301.","journal-title":"Biomicrofluidics"},{"issue":"39","key":"3719_CR37","doi-asserted-by":"publisher","first-page":"15885","DOI":"10.1039\/D3NR03327A","volume":"15","author":"D Li","year":"2023","unstructured":"Li D, Fan T, Mei X. A comprehensive exploration of the latest innovations for advancements in enhancing selectivity of nanozymes for theranostic nanoplatforms. Nanoscale. 2023;15(39):15885\u2013905.","journal-title":"Nanoscale"},{"issue":"10","key":"3719_CR38","first-page":"71","volume":"6","author":"H Ali","year":"2022","unstructured":"Ali H. Ai in neurodegenerative disease research: early detection, cognitive decline prediction, and brain imaging biomarker identification. Int J Eng Technol Res Manag. 2022;6(10):71.","journal-title":"Int J Eng Technol Res Manag"},{"issue":"3","key":"3719_CR39","doi-asserted-by":"publisher","first-page":"342","DOI":"10.26599\/NBE.2023.9290035","volume":"15","author":"X Zhu","year":"2023","unstructured":"Zhu X, Li Y, Gu N. Application of artificial intelligence in the exploration and optimization of biomedical nanomaterials. Nano Biomed Eng. 2023;15(3):342\u201353. https:\/\/doi.org\/10.26599\/NBE.2023.9290035.","journal-title":"Nano Biomed Eng"},{"issue":"7674","key":"3719_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nature23912","volume":"550","author":"A Chevalier","year":"2017","unstructured":"Chevalier A, et al. Massively parallel de novo protein design for targeted therapeutics. Nature. 2017;550(7674):74\u20139. https:\/\/doi.org\/10.1038\/nature23912.","journal-title":"Nature"},{"issue":"2","key":"3719_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20230137","volume":"5","author":"S Pawar","year":"2025","unstructured":"Pawar S, Rauf MA, Abdelhady H, Iyer AK. Tau-targeting nanoparticles for treatment of Alzheimer\u2019s disease. Exploration. 2025;5(2):20230137.","journal-title":"Exploration"},{"issue":"5","key":"3719_CR42","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.drudis.2018.01.047","volume":"23","author":"V Agrahari","year":"2018","unstructured":"Agrahari V, Agrahari V. Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities. Drug Discov Today. 2018;23(5):1119\u201328.","journal-title":"Drug Discov Today"},{"key":"3719_CR43","doi-asserted-by":"publisher","first-page":"331","DOI":"10.26599\/NBE.2024.9290096","volume":"3","author":"H Zhu","year":"2024","unstructured":"Zhu H, Fan J, Yang C, Liu J, Ding B. DNA nanocarriers for delivery of sgRNA\/Cas9 ribonucleoprotein. Nano Biomed Eng. 2024;3:331\u201344. https:\/\/doi.org\/10.26599\/NBE.2024.9290096.","journal-title":"Nano Biomed Eng"},{"issue":"Suppl 1","key":"3719_CR44","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.2967\/jnumed.121.263202","volume":"63","author":"H Barthel","year":"2022","unstructured":"Barthel H, Villemagne VL, Drzezga A. Future directions in molecular imaging of neurodegenerative disorders. J Nucl Med. 2022;63(Suppl 1):S68\u201374.","journal-title":"J Nucl Med"},{"issue":"4","key":"3719_CR45","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/cpt.2544","volume":"111","author":"S Janicki Hsieh","year":"2022","unstructured":"Janicki Hsieh S, Alexopoulou Z, Mehrotra N, Struyk A, Stoch SA. Neurodegenerative diseases: the value of early predictive end points. Clin Pharmacol Ther. 2022;111(4):835\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"3719_CR46","doi-asserted-by":"crossref","unstructured":"Yingngam B. AI-driven drug discovery and repurposing for neurodegenerative disorders. In: Jena B, Saxena S, Paul S, editors.Machine learning for neurodegenerative disorders: Advancements and Applications. Boca Raton: CRC; 2024. p. 80\u2013124.","DOI":"10.1201\/9781032661025-4"},{"issue":"5","key":"3719_CR47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1208\/s12248-024-00987-0","volume":"26","author":"K Klein","year":"2024","unstructured":"Klein K, Langhof H, Ehmann F, Tzara A, Giuliani A, Reischl IG, et al. Heterogeneity of regulatory approval pathways for nanomedicinal products in the EU\u2014but broadly applicable to nanocarriers including those targeting the BBB. AAPS J. 2024;26(5):102. https:\/\/doi.org\/10.1208\/s12248-024-00987-0.","journal-title":"AAPS J"},{"key":"3719_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20230029","author":"Y Dong","year":"2024","unstructured":"Dong Y, Xu T, Yuan L, Wang Y, Yu S, Wang Z, et al. Cerebrospinal fluid efflux through dynamic paracellular pores on venules as a missing piece of the brain drainage system. Exploration. 2024. https:\/\/doi.org\/10.1002\/EXP.20230029.","journal-title":"Exploration"},{"key":"3719_CR49","unstructured":"Luo Y, Xiang Y, Liu J, Hu Y, Guo J. A multi-omics framework based on machine learning as a predictor of cognitive impairment progression in early parkinson\u2019s disease. Neurol Ther. 2025 22:1\u20136."},{"key":"3719_CR50","doi-asserted-by":"publisher","DOI":"10.2196\/42672","volume":"25","author":"A Abd-Alrazaq","year":"2023","unstructured":"Abd-Alrazaq A, AlSaad R, Aziz S, Ahmed A, Denecke K, Househ M, et al. Wearable artificial intelligence for anxiety and depression: scoping review. J Med Internet Res. 2023;25:e42672.","journal-title":"J Med Internet Res"},{"issue":"1","key":"3719_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.26599\/NBE.2024.9290102","volume":"17","author":"X Li","year":"2025","unstructured":"Li X, Wang T, Li W. Advanced diagnostic and therapeutic systems based on second near-infrared photoacoustic imaging. Nano Biomed Eng. 2025;17(1):17\u201335. https:\/\/doi.org\/10.26599\/NBE.2024.9290102.","journal-title":"Nano Biomed Eng"},{"issue":"2","key":"3719_CR52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.26599\/NBE.2024.9290061","volume":"16","author":"Y Guo","year":"2024","unstructured":"Guo Y, Li Z, Guo B, Wang B, Tu Y. Targeting-specific nanoprobes in the second near-infrared window for biomedical applications. Nano Biomed Eng. 2024;16(2):135\u201351. https:\/\/doi.org\/10.26599\/NBE.2024.9290061.","journal-title":"Nano Biomed Eng"},{"issue":"7","key":"3719_CR53","first-page":"4052","volume":"61","author":"R Sinha","year":"2024","unstructured":"Sinha R, Kaur G, Verma A, Chauhan SS, Singh A. Gazing beyond the horizon: a systematic review unveiling the theranostic potential of quantum dots in Alzheimer\u2019s disease. Mol Neurobiol. 2024;61(7):4052\u201367.","journal-title":"Mol Neurobiol"},{"key":"3719_CR54","doi-asserted-by":"crossref","unstructured":"Qiu Q, Li S, Zhang J, Chen J, Ding X, Liu S, et al. Lab-in-the-loop machine learning for brain-targeting delivery system design. Cell Biomaterials. 2025;30:443.","DOI":"10.1016\/j.celbio.2025.100130"},{"key":"3719_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1477-3155-10-27","volume":"10","author":"IY Goon","year":"2012","unstructured":"Goon IY, Dzamukova M, Ju QJ, Kj\u00e6r EG, Lee JSH, Rosser SJ, et al. Hybrid gold\u2013iron oxide nanoparticles as a multifunctional platform for biomedical application. J Nanobiotechnol. 2012;10:27.","journal-title":"J Nanobiotechnol"},{"key":"3719_CR56","doi-asserted-by":"crossref","unstructured":"Mathur S, Bhattacharjee S, Sehgal S, Shekhar R. Role of artificial intelligence and internet of things in neurodegenerative diseases. In: Gaur L, Abraham A, Ajith R, editors. AI and neuro-degenerative diseases: insights and solutions. Cham: Springer Nature Switzerland; 2024. p. 35\u201362.","DOI":"10.1007\/978-3-031-53148-4_2"},{"key":"3719_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2024.1458690","volume":"12","author":"C Peng","year":"2024","unstructured":"Peng C. Editorial: nanomedicine development and clinical translation. Front Chem. 2024;12:1458690.","journal-title":"Front Chem"},{"key":"3719_CR58","doi-asserted-by":"publisher","unstructured":"Mohsen, S. Alzheimer\u2019s disease detection using deep learning and machine learning: a review. Artif Intell Rev 2025;58:262. https:\/\/doi.org\/10.1007\/s10462-025-11258-y","DOI":"10.1007\/s10462-025-11258-y"},{"issue":"1","key":"3719_CR59","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13195-022-00985-X","volume":"14","author":"MS Lam","year":"2022","unstructured":"Lam MS, Lowe VJ, Weigand SD, et al. A deep learning MRI approach outperforms other biomarkers of prodromal alzheimer\u2019s disease. Alzheimers Res Ther. 2022;14(1):162. https:\/\/doi.org\/10.1186\/s13195-022-00985-X.","journal-title":"Alzheimers Res Ther"},{"key":"3719_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.01.027","author":"C Peng","year":"2025","unstructured":"Peng C. AI-powered model for accurate prediction of MCI-to-AD progression. Acta Pharm Sin B. 2025. https:\/\/doi.org\/10.1016\/j.apsb.2025.01.027. In press.","journal-title":"Acta Pharm Sin B"},{"key":"3719_CR61","doi-asserted-by":"publisher","unstructured":"Tang X, Dai H, Knight E, Wu F, Li Y, Li T, Gerstein M. A survey of generative AI for de Novo drug design: new frontiers in molecule and protein generation. Briefings in Bioinformatics 2024; 25(4):bbae338. https:\/\/doi.org\/10.1093\/bib\/bbae338","DOI":"10.1093\/bib\/bbae338"},{"key":"3719_CR62","unstructured":"Zhan A, Little MA, Harris DA, Abiola SO, Dorsey ER, Saria S et al. High frequency remote monitoring of Parkinson\u2019s disease via smartphone: Platform overview and medication response detection. arXiv preprint. 2016 Jan 5. Available from: https:\/\/arxiv.org\/abs\/1601.00960"},{"key":"3719_CR63","volume":"18","author":"R Sedano","year":"2025","unstructured":"Sedano R, Solitano V, Vuyyuru SK, Yuan Y, Han\u017eel J, Ma C, et al. AI-driven innovations in smart multifunctional nanocarriers for drug and gene delivery: a mini-review. Adv Drug Deliv Rev. 2025;18:17562848251321915.","journal-title":"Adv Drug Deliv Rev"},{"key":"3719_CR64","first-page":"717220","volume":"15","author":"Z Ma","year":"2021","unstructured":"Ma Z, Zhang J, Lu C, et al. Diffusion magnetic resonance imaging\u2013based biomarkers for parkinson\u2019s disease. Front Neurosci. 2021;15:717220.","journal-title":"Front Neurosci"},{"issue":"4","key":"3719_CR65","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3390\/biom11040565","volume":"11","author":"S Takahashi","year":"2021","unstructured":"Takahashi S, Takahashi M, Tanaka S, Takayanagi S, Takami H, Yamazawa E, Nambu S, Miyake M, Satomi K, Ichimura K, Narita Y. A new era of neuro-oncology research pioneered by multi-omics analysis and machine learning. Biomolecules. 2021;11(4):565.","journal-title":"Biomolecules"},{"key":"3719_CR66","doi-asserted-by":"publisher","first-page":"108564","DOI":"10.1016\/j.compbiomed.2024.108564","volume":"176","author":"X Liu","year":"2024","unstructured":"Liu X, Li W, Miao S, Liu F, Han K, Bezabih TT, et al. Automated detection of alzheimer\u2019s disease: A multi-modal approach with 3D MRI and amyloid PET. Comput Biol Med. 2024;176:108564. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108564.","journal-title":"Comput Biol Med"},{"issue":"5","key":"3719_CR67","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00415-019-09518-3","volume":"268","author":"UK Patel","year":"2021","unstructured":"Patel UK, Anwar A, Saleem S, Malik P, Rasul B, Patel K, Yao R, Seshadri A, Yousufuddin M, Arumaithurai K. Artificial intelligence as an emerging technology in the current care of neurological disorders. J Neurol. 2021;268(5):1623\u201342.","journal-title":"J Neurol"},{"issue":"2","key":"3719_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14020550","volume":"14","author":"R Onciul","year":"2025","unstructured":"Onciul R, Tataru CI, Dumitru AV, Crivoi C, Serban M, Covache-Busuioc RA, et al. Artificial intelligence and neuroscience: transformative synergies in brain research and clinical applications. J Clin Med. 2025;14(2):550.","journal-title":"J Clin Med"},{"key":"3719_CR69","doi-asserted-by":"crossref","unstructured":"Elabiad S. Nano-consciousness: can nanotechnology Bridge artificial intelligence and human brain interfaces. Available SSRN. 2025 ;5126732:1.","DOI":"10.2139\/ssrn.5126732"},{"key":"3719_CR70","doi-asserted-by":"crossref","unstructured":"Sahi KS, Kaushik S. Smart nanosensors for healthcare monitoring and disease detection using AIoT framework. In: Nanosensors for futuristic smart and intelligent healthcare systems. 2022 pp. 387\u2013400. CRC.","DOI":"10.1201\/9781003093534-19"},{"issue":"4","key":"3719_CR71","first-page":"377","volume":"10","author":"JC Chen","year":"2025","unstructured":"Chen JC, Ziegler DA. Closed-loop systems and real-time neurofeedback in mindfulness meditation research. Biol Psychiatry Cogn Neurosci Neuroimaging. 2025;10(4):377\u201383.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"3719_CR72","doi-asserted-by":"publisher","first-page":"1085173","DOI":"10.3389\/fnhum.2023.1085173","volume":"17","author":"AN Belkacem","year":"2023","unstructured":"Belkacem AN, Jamil N, Khalid S, Alnajjar F. On closed-loop brain stimulation systems for improving the quality of life of patients with neurological disorders. Front Hum Neurosci. 2023;17:1085173.","journal-title":"Front Hum Neurosci"},{"issue":"1","key":"3719_CR73","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12984-025-01345-7","volume":"22","author":"R Shi","year":"2025","unstructured":"Shi R, Cai L, Wu B, Yang S, Xiong H, Cheng M. Computational neurorehabilitation via modular intelligent systems: enabling data interoperability and clinician-integrated workflows. J Neuroeng Rehabil. 2025;22(1):42. https:\/\/doi.org\/10.1186\/s12984-025-01345-7.","journal-title":"J Neuroeng Rehabil"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03719-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03719-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03719-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:00:43Z","timestamp":1781611243000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03719-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3719"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03719-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"668"}}